Literature DB >> 23047773

Synaptic circuit remodelling by matrix metalloproteinases in health and disease.

George W Huntley1.   

Abstract

Matrix metalloproteinases (MMPs) are extracellularly acting enzymes that have long been known to have deleterious roles in brain injury and disease. In particular, widespread and protracted MMP activity can contribute to neuronal loss and synaptic dysfunction. However, recent studies show that rapid and focal MMP-mediated proteolysis proactively drives synaptic structural and functional remodelling that is crucial for ongoing cognitive processes. Deficits in synaptic remodelling are associated with psychiatric and neurological disorders, and aberrant MMP expression or function may contribute to the molecular mechanisms underlying these deficits. This Review explores the paradigm shift in our understanding of the contribution of MMPs to normal and abnormal synaptic plasticity and function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23047773      PMCID: PMC4900464          DOI: 10.1038/nrn3320

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  154 in total

1.  Evidence that integrins contribute to multiple stages in the consolidation of long term potentiation in rat hippocampus.

Authors:  D Chun; C M Gall; X Bi; G Lynch
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  GluR1 links structural and functional plasticity at excitatory synapses.

Authors:  Charles D Kopec; Eleonore Real; Helmut W Kessels; Roberto Malinow
Journal:  J Neurosci       Date:  2007-12-12       Impact factor: 6.167

3.  Polarized distribution and cell type-specific localization of telencephalin, an intercellular adhesion molecule.

Authors:  D L Benson; Y Yoshihara; K Mori
Journal:  J Neurosci Res       Date:  1998-04-01       Impact factor: 4.164

Review 4.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.

Authors:  S Rajaram; D J Baylink; S Mohan
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

5.  Neuropsin regulates an early phase of schaffer-collateral long-term potentiation in the murine hippocampus.

Authors:  S Komai; T Matsuyama; K Matsumoto; K Kato; M Kobayashi; K Imamura; S Yoshida; S Ugawa; S Shiosaka
Journal:  Eur J Neurosci       Date:  2000-04       Impact factor: 3.386

6.  Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis.

Authors:  H J Kim; H L Fillmore; T M Reeves; L L Phillips
Journal:  Exp Neurol       Date:  2005-03       Impact factor: 5.330

7.  Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength.

Authors:  Hakjoo Lee; Stephen J Raiker; Karthik Venkatesh; Rebecca Geary; Laurie A Robak; Yu Zhang; Hermes H Yeh; Peter Shrager; Roman J Giger
Journal:  J Neurosci       Date:  2008-03-12       Impact factor: 6.167

8.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

9.  Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.

Authors:  P A Forsyth; H Wong; T D Laing; N B Rewcastle; D G Morris; H Muzik; K J Leco; R N Johnston; P M Brasher; G Sutherland; D R Edwards
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  A critical role for IGF-II in memory consolidation and enhancement.

Authors:  Dillon Y Chen; Sarah A Stern; Ana Garcia-Osta; Bernadette Saunier-Rebori; Gabriella Pollonini; Dhananjay Bambah-Mukku; Robert D Blitzer; Cristina M Alberini
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

View more
  123 in total

Review 1.  Pharmacological therapies for Angelman syndrome.

Authors:  Wen-Hann Tan; Lynne M Bird
Journal:  Wien Med Wochenschr       Date:  2016-01-12

Review 2.  The tetrapartite synapse: Extracellular matrix remodeling contributes to corticoaccumbens plasticity underlying drug addiction.

Authors:  Alexander C W Smith; Michael D Scofield; Peter W Kalivas
Journal:  Brain Res       Date:  2015-03-30       Impact factor: 3.252

Review 3.  Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia.

Authors:  Katarzyna Lepeta; Leszek Kaczmarek
Journal:  Schizophr Bull       Date:  2015-04-02       Impact factor: 9.306

Review 4.  The good and bad news about glutamate in drug addiction.

Authors:  Sade Spencer; Michael Scofield; Peter W Kalivas
Journal:  J Psychopharmacol       Date:  2016-06-28       Impact factor: 4.153

Review 5.  Integrins in synapse regulation.

Authors:  Yun Kyung Park; Yukiko Goda
Journal:  Nat Rev Neurosci       Date:  2016-11-04       Impact factor: 34.870

6.  Early postnatal expression and localization of matrix metalloproteinases-2 and -9 during establishment of rat hippocampal synaptic circuitry.

Authors:  Paven K Aujla; George W Huntley
Journal:  J Comp Neurol       Date:  2014-04-15       Impact factor: 3.215

Review 7.  Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction.

Authors:  Daniela Neuhofer; Peter Kalivas
Journal:  Neurobiol Learn Mem       Date:  2018-02-09       Impact factor: 2.877

8.  The role of matrix metalloproteinase-9 in negative reinforcement learning and plasticity in alcohol dependence.

Authors:  Bok Soon Go; Sunil Sirohi; Brendan M Walker
Journal:  Addict Biol       Date:  2019-01-16       Impact factor: 4.280

Review 9.  The Opioid-Addicted Tetrapartite Synapse.

Authors:  Anna Kruyer; Vivian C Chioma; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2019-06-13       Impact factor: 13.382

10.  Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.

Authors:  Thomas Bordenave; Marion Helle; Fabrice Beau; Dimitris Georgiadis; Livia Tepshi; Mylène Bernes; Yunpeng Ye; Laure Levenez; Enora Poquet; Hervé Nozach; Mahmoud Razavian; Jakub Toczek; Enrico A Stura; Vincent Dive; Mehran M Sadeghi; Laurent Devel
Journal:  Bioconjug Chem       Date:  2016-09-14       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.